Limited cross strain CMV protection by a bivalent (gB/pp65) vaccine is based on an impaired gB antibody response and evasion of pp65 cell mediated immunity
K.Yeon Choi, Yushu Qin, Nadia S. El‐Hamdi, Alistair McGregor
This study evaluates a bivalent GPCMV vaccine and finds it provides limited cross-strain protection due to impaired gB antibody response and evasion of pp65 cell-mediated immunity.
bioRxiv · Oct 29, 2026 · PreprintMicrobiology